The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (17)
Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated Patients
1989 • 877 citations
Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan
1988 • 618 citations
Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. I. Untreated Patients
1989 • 269 citations
Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radiation Treated Patients
1989 • 230 citations
Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. IV. Anti-Androgen Treated Patients
1989 • 212 citations
The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer
1984 • 177 citations
Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate
1979 • 140 citations
Prostate Specific Antigen in Hormonally Treated Stage D2 Prostate Cancer: Is it always an Accurate Indicator of Disease Status?
1991 • 124 citations
Prognostic factors in patients with advanced stage prostate cancer.
1985 • 123 citations
Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome.
1988 • 114 citations
Prostate Specific Antigen Values after Radical Retropubic Prostatectomy for Adenocarcinoma of the Prostate: Impact of Adjuvant Treatment (Hormonal and Radiation)
1991 • 96 citations
Comparative Experimental Study of the Serum Prostate Specific Antigen and Prostatic Acid Phosphatase in Serially Transplantable Human Prostatic Carcinoma Lines in Nude Mice
1988 • 50 citations
Treatment of Metastatic Endocrine-Unresponsive Carcinoma of the Prostate Gland With Multiagent Chemotherapy: indicators of Response to Therapy2
1979 • 44 citations
The endocrinology and treatment of prostate tumor progression.
1987 • 35 citations
Contribution of Bone Scintigraphy, Prostatic Acid Phosphatase and Prostate-Specific Antigen to the Monitoring of Prostatic Cancer
1988 • 28 citations
Contribution of Bone Scintigraphy, Prostatic Acid Phosphatase and Prostate-Specific Antigen to the Monitoring of Prostatic Cancer
1989 • 23 citations
The Role of Prostate Specific Antigen in the Baseline Assessment of Patients undergoing Hormone Therapy for Advanced Prostate Cancer
1987 • 11 citations
Cited By (0)
No citing papers found in database